Jonathon Marks-Bluth

Jonathon Marks-Bluth has extensive work experience in the field of business development and portfolio strategy. Jonathon is currently the Director of Business Development at Alchemab Therapeutics Ltd, starting in 2022. Prior to that, they worked at Orchard Therapeutics, where they held various roles including Director of Business Development and Portfolio Strategy, Associate Director, Senior Manager, and Program and Portfolio Manager. Jonathon also had experience at IQVIA as a Manager and Consultant, and at Candesic as an Analyst. Jonathon began their career as a Visiting Graduate Student at the University of Oxford and as a Doctoral Candidate at the Lowy Cancer Research Center. Jonathon also worked as an Undergraduate Research Assistant at the Garvan Institute of Medical Research and as an Intern at WorleyParsons.

Jonathon Marks-Bluth completed their education at UNSW. Jonathon obtained a Bachelor of Commerce (BCom) degree in Business/Managerial Economics from 2005 to 2009. From 2005 to 2010, they pursued a Bachelor of Science (BSc) (Hons 1) degree in Molecular Biology. Lastly, from 2011 to 2014, they earned a Doctor of Philosophy (Ph.D.) in Medicine.